Literature DB >> 10490268

Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion.

M C McDonald1, K Zacharowski, J Bowes, S Cuzzocrea, C Thiemermann.   

Abstract

Reactive oxygen species (ROS) contribute to ischemia-reperfusion injury of the heart. This study investigates the effects of tempol, a membrane-permeable radical scavenger on (i) the infarct size caused by regional myocardial ischemia and reperfusion of the heart in vivo (rat, rabbit) and in vitro (rat), and (ii) the cell injury caused by hydrogen peroxide (H2O2) in rat cardiac myoblasts (H9c2 cells). In the anesthetized rat, tempol reduced the infarct size caused by regional myocardial ischemia (25 min) and reperfusion (2 h) from 60 +/- 3% (control, n = 8) to 24 +/- 5% (n = 6, p < .05). In the anesthetized rabbit, tempol also attenuated the infarct size caused by myocardial ischemia (45 min) and reperfusion (2 h) from 59 +/- 3% (control, n = 6) to 39 +/- 5% (n = 5, p < .05). Regional ischemia (35 min) and reperfusion (2 h) of the isolated, buffer-perfused heart of the rat resulted in an infarct size of 54 +/- 4% (control n = 7). Reperfusion of hearts with buffer containing tempol (n = 6) caused a 37% reduction in infarct size (n = 6, p < .05). Pretreatment of rat cardiac myoblasts with tempol attenuated the impairment in mitochondrial respiration caused by H2O2 (1 mM for 4 h). Thus, the membrane-permeable radical scavenger tempol reduces myocardial infarct size in rodents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490268     DOI: 10.1016/s0891-5849(99)00100-8

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  25 in total

1.  Antioxidant action of a lipophilic nitroxyl radical, cyclohexane-1-spiro-2'-(4'-oxyimidazolidine-1'-oxyl) -5'-spiro-1"-cyclohexane, against lipid peroxidation under hypoxic conditions.

Authors:  Shuichi Shimakawa; Yasukazu Yoshida; Etsuo Niki
Journal:  Lipids       Date:  2003-03       Impact factor: 1.880

2.  Tempol protects the gallbladder against ischemia/reperfusion.

Authors:  Pedro J Gomez-Pinilla; Pedro J Camello; Jesus A F Tresguerres; María José Pozo
Journal:  J Physiol Biochem       Date:  2010-06-23       Impact factor: 4.158

3.  Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion.

Authors:  Gabriel Loor; Jyothisri Kondapalli; Hirotaro Iwase; Navdeep S Chandel; Gregory B Waypa; Robert D Guzy; Terry L Vanden Hoek; Paul T Schumacker
Journal:  Biochim Biophys Acta       Date:  2010-12-23

4.  Can MitoTEMPO protect rat sciatic nerve against ischemia-reperfusion injury?

Authors:  Seckin Tuncer; Ahmet Akkoca; Murat Cenk Celen; Nizamettin Dalkilic
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-07       Impact factor: 3.000

Review 5.  Mitochondrial function in hypoxic ischemic injury and influence of aging.

Authors:  P Benson Ham; Raghavan Raju
Journal:  Prog Neurobiol       Date:  2016-06-16       Impact factor: 11.685

6.  Antioxidant properties of MitoTEMPOL and its hydroxylamine.

Authors:  Jan Trnka; Frances H Blaikie; Angela Logan; Robin A J Smith; Michael P Murphy
Journal:  Free Radic Res       Date:  2009-01

7.  Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes.

Authors:  Masahiro Yamawaki; Norihito Sasaki; Masaki Shimoyama; Junichiro Miake; Kazuhide Ogino; Osamu Igawa; Fumito Tajima; Chiaki Shigemasa; Ichiro Hisatome
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

8.  Tempol reduces bacterial translocation after ischemia/reperfusion injury in a rat model of superior mesenteric artery occlusion.

Authors:  Ibrahim Berber; Cagatay Aydin; Nural Cevahir; Cigdem Yenisey; Gulistan Gumrukcu; Goksel Kocbil; Gurkan Tellioglu; Koray Tekin
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

9.  High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury.

Authors:  An L Moens; Hunter C Champion; Marc J Claeys; Barbara Tavazzi; Pawel M Kaminski; Michael S Wolin; Dirk J Borgonjon; Luc Van Nassauw; Azeb Haile; Muz Zviman; Djahida Bedja; Floris L Wuyts; Rebecca S Elsaesser; Paul Cos; Kathy L Gabrielson; Giuseppe Lazzarino; Nazareno Paolocci; Jean-Pierre Timmermans; Christiaan J Vrints; David A Kass
Journal:  Circulation       Date:  2008-03-24       Impact factor: 29.690

Review 10.  The chemistry and biology of nitroxide compounds.

Authors:  Benjamin P Soule; Fuminori Hyodo; Ken-Ichiro Matsumoto; Nicole L Simone; John A Cook; Murali C Krishna; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2007-03-12       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.